Curocell’s CAR-T therapy Lymcato has passed the Health Insurance Review and Assessment Service’s drug reimbursement review, accelerating its path toward national health insurance coverage this year.

Onconic Therapeutics reveals Nesuparib's promising preclinical results for small cell lung cancer, outperforming existing treatments significantly.

North Korea's economy shows signs of recovery with a 10% growth over five years, driven by industrial and agricultural sectors despite inflation risks.